Cargando…

Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma

Chronic Hepatitis B is a highly prevalent disease worldwide and is estimated to cause more than 800000 annual deaths from complications such as cirrhosis and hepatocellular carcinoma (HCC). Although universal hepatitis B vaccination programs may have reduced the incidence and prevalence of chronic h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gnyawali, Bipul, Pusateri, Antoinette, Nickerson, Ashley, Jalil, Sajid, Mumtaz, Khalid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367226/ https://www.ncbi.nlm.nih.gov/pubmed/36157533 http://dx.doi.org/10.3748/wjg.v28.i29.3793

Ejemplares similares

Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis
por: Pusateri, Antoinette, et al.
Publicado: (2023)

Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
por: Irshad, Mohammad, et al.
Publicado: (2017)

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
por: Lee, Hye Won, et al.
Publicado: (2016)

Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
por: Guo, Jiang, et al.
Publicado: (2021)

Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
por: Meringer, Hadar, et al.
Publicado: (2019)

Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review
por: Gigi, Eleni, et al.
Publicado: (2018)

Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
por: Muzica, Cristina Maria, et al.
Publicado: (2020)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
por: Baumert, Thomas F., et al.
Publicado: (2017)

Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
por: Kamal, Ahmed, et al.
Publicado: (2022)

Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2022)

Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
por: Shi, Yi-Xian, et al.
Publicado: (2016)

Hepatitis B virus reactivation in rheumatoid arthritis
por: Wu, Ya-Li, et al.
Publicado: (2022)

Treatment of hepatitis B virus infection in children and adolescents
por: Stinco, Mariangela, et al.
Publicado: (2021)

Prevention of vertical transmission of hepatitis B virus infection
por: Veronese, Piero, et al.
Publicado: (2021)

Human immune repertoire in hepatitis B virus infection
por: Zhan, Qiao, et al.
Publicado: (2021)

Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
por: Guarino, Maria, et al.
Publicado: (2018)

Treatment for hepatocellular carcinoma with tumor thrombosis in the hepatic vein or inferior vena cava: A comprehensive review
por: Zhang, Zun-Yi, et al.
Publicado: (2021)

Migration of Gastric Varix Coil After Balloon-Occluded Antegrade Transvenous Obliteration
por: Pusateri, Antoinette J., et al.
Publicado: (2020)

New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
por: Dennis, Brittany B, et al.
Publicado: (2021)

Hepatitis B virus-persistent infection and innate immunity defect: Cell-related or virus-related?
por: Tang, Jian, et al.
Publicado: (2018)

Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data
por: Aljabban, Jihad, et al.
Publicado: (2022)

Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
por: Crismale, James F, et al.
Publicado: (2019)

Nutritional therapy for hepatocellular carcinoma
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023)

Update on global epidemiology of viral hepatitis and preventive strategies
por: Jefferies, Meryem, et al.
Publicado: (2018)

Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule
por: Liu, Qiushi, et al.
Publicado: (2016)

Interaction between hepatitis B virus and SARS-CoV-2 infections
por: Xiang, Tian-Dan, et al.
Publicado: (2021)

Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
por: Zane, Kylie E, et al.
Publicado: (2022)

Functional interaction of endoplasmic reticulum stress and hepatitis B virus in the pathogenesis of liver diseases
por: Kim, So Young, et al.
Publicado: (2017)

Molecular therapy for the treatment of hepatocellular carcinoma
por: Greten, T F, et al.
Publicado: (2009)

Dimensions of hepatocellular carcinoma phenotypic diversity
por: Désert, Romain, et al.
Publicado: (2018)

Hepatocellular carcinoma – time to take the ticket
por: Mullath, Anju, et al.
Publicado: (2019)

Update on hepatocellular carcinoma: Pathologists’ review
por: El Jabbour, Tony, et al.
Publicado: (2019)

Characterization of metabolic landscape in hepatocellular carcinoma
por: Wu, Jing, et al.
Publicado: (2021)

Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
por: Russo, Edda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j1iaujtp8ah18armskj985l32f